Filing search / Iovance Biotherapeutics, Inc. / "Incident" / Page 2

8-K

EX-1.1

t3r i62a8j

29 May 20

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

4:22pm

8-K

EX-3.1

f32xx bgp

27 May 20

Iovance Reports Pivotal Cohort 4 Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel from

4:02pm

8-K

EX-1.1

sisf5m

12 Oct 18

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

4:06pm

8-K

EX-1.1

fld2r9fyb75o7

3 Mar 15

Lion Biotechnologies Announces Public Offering of

12:00am

8-K

EX-1.1

2cqyg2jvtsuz1d

22 Dec 14

Lion Biotechnologies Announces Pricing of Underwritten Common Stock Offering

12:00am

8-K

EX-10.1

00x0m 7az0q0

26 Aug 14

Departure of Directors or Certain Officers

12:00am

8-K

EX-10.1

8rny8v zxe

19 May 14

Departure of Directors or Certain Officers

12:00am

8-K

EX-10.1

emcuemcxjh6x bz7r

31 Oct 13

Entry into a Material Definitive Agreement

12:00am